iRhythm Technologies Announces Japanese Regulatory Approval of the Zio® ECG Monitoring System, the First Product to Deliver Arrhythmia Monitoring Service Utilizing Artificial Intelligence
September 11, 2024 08:05 ET
|
iRhythm
Zio ECG monitoring system is the only fourteen-day cardiac monitoring service in its category to receive Japanese regulatory approval as an improved device without a clinical trialZio ECG monitoring...
iRhythm Unveils Data Demonstrating Superior Real-World Performance of Next-Generation Zio® Monitor at HRX 2024 Meeting
September 09, 2024 08:05 ET
|
iRhythm
New data shows iRhythm’s next-generation Zio monitor LTCM patch ECG device superior real-world performance compared to prior generation device.
iRhythm Technologies Enters License Agreement with BioIntelliSense for Multiparameter Sensor Technology to be Used in Ambulatory Cardiac Monitoring
September 04, 2024 07:30 ET
|
iRhythm
SAN FRANCISCO, Sept. 04, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and...
iRhythm Technologies Announces Results of GUARD-AF Trial
September 01, 2024 13:33 ET
|
iRhythm
GUARD-AF trial results presented at European Society of Cardiology (ESC) Congress 2024
iRhythm Technologies amplia la portata globale con il lancio del servizio di monitoraggio dell’aritmia cardiaca Zio® in Austria, Paesi Bassi, Svizzera e Spagna
August 29, 2024 08:00 ET
|
iRhythm
Il servizio di monitoraggio continuo a lungo termine (LTCM) Zio consiste in un dispositivo di monitoraggio ECG con cerotto esclusivamente su prescrizione (Zio® monitor) da indossare per un massimo di...
iRhythm Technologies élargit sa portée mondiale avec le lancement, en Autriche, aux Pays-Bas, en Suisse et en Espagne, du service de surveillance de l’arythmie cardiaque Zio®
August 29, 2024 08:00 ET
|
iRhythm
La surveillance continue à long terme (long term continuous monitoring, LTCM) Zio service comprend un dispositif de surveillance ECG par patch exclusivement sur ordonnance (Zio® moniteur) porté...
iRhythm Technologies erweitert seine globale Reichweite mit der Einführung des Zio®-Dienstes zur Überwachung von Herzrhythmusstörungen (Cardiac Arrhythmia Monitoring Service) in den Niederlanden, Österreich, der Schweiz und Spanien
August 29, 2024 08:00 ET
|
iRhythm
Der Zio-Dienst, ein System zur kontinuierliche Langzeit-Überwachung (Long-term Continuous Monitoring, LTCM), besteht aus einem verschreibungspflichtigen Monitor, dem EKG-Überwachungsprodukt...
iRhythm Technologies Expands Global Reach with the Launch of Zio® Cardiac Arrhythmia Monitoring Service in Austria, the Netherlands, Switzerland, and Spain
August 29, 2024 08:00 ET
|
iRhythm
Zio long-term continuous monitoring (LTCM) service consists of a prescription only patch ECG monitoring device (Zio monitor) worn for up to 14 days, the ZEUS (Zio ECG Utilization Software) System...
iRhythm Technologies Expands Global Reach with the Launch of Zio® Cardiac Arrhythmia Monitoring Service in Austria, the Netherlands, Switzerland, and Spain
August 29, 2024 08:00 ET
|
iRhythm
Zio long-term continuous monitoring (LTCM) service consists of a prescription only patch ECG monitoring device (Zio monitor) worn for up to 14 days, the ZEUS (Zio ECG Utilization Software) System...
iRhythm Technologies breidt uit in Oostenrijk, Nederland, Zwitserland en Spanje met Zio® monitor hartritmestoornismonitoring
August 29, 2024 08:00 ET
|
iRhythm
De Zio-service voor langdurige doorlopende monitoring (LTCM) bestaat uit een ECG-monitor (Zio®-monitor) die op voorschrift gedurende maximaal 14 dagen kan worden gedragen, het ZEUS-systeem (Zio ECG...